Genetic modification therapy incorporates a functional gene into a cell-based therapy. The genetic modification generally occurs outside the body, but the resulting genetic change to the patient's DNA is permanent. The active payload comprise of the gene encoding for production of the therapeutic protein and gene controls that regulates production of the therapeutic gene. The vector, which may be either non-viral or viral, delivers the gene and gene control payload to the cells which are to be genetically modified. The most common cell types include T cells, and HSCs. Genetic modification has brought a milestone into medicine. Genetic modification is very crucial in treating severe diseases.
MARKET DYNAMICS
The key market drivers for Genetic Modification Therapies Market Includes, rising applications of genetic modification therapies into treatment of diseases and disorders. Moreover, technological advancement into biotechnology studies has also fueled market growth. Additionally, increasing R&D investments by pharmaceutical and biotechnology industries is also expected to boost market growth during forecast period. However, unethical use of technology along with lack of awareness about genetic medication therapy is expected to restrain market growth during forecast period.
MARKET SCOPE
The "Genetic Modification Therapies Market" is a specialized and in-depth study of the Biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Genetic Modification Therapies market with detailed market segmentation by platform technology, delivery technology, end user and disease. The Genetic Modification Therapies Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Genetic Modification Therapies Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Genetic Modification Therapies Market is segmented on the basis of platform technology, delivery technology, end user and disease. On the basis of platform technology the market is segmented as, gene therapy, gene editing, genetically modified cell therapies, RNA therapies. On the basis of delivery technology the market is segmented as, AAV, Adenovirus, lentivirus, retrovirus, others. On the basis of end user the market is segmented as, hospitals, diagnostics and testing laboratories, academic and research organizations, others. And on the basis of disease the market is segmented as, cardiology, oncology, ophthalmology, hematology, neurology and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Genetic Modification Therapies Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Genetic Modification Therapies Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Genetic Modification Therapies Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Genetic Modification Therapies Market in these regions.
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Genetic Modification Therapies Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Genetic Modification Therapies Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Genetic Modification Therapies Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Genetic Modification Therapies Market in these regions.
MARKET PLAYERS
The report covers key developments in the Genetic Modification Therapies Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Genetic Modification Therapies Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Genetic Modification Therapies market in the global market. Below mentioned is the list of few companies engaged in the Genetic Modification Therapies Market.
The report also includes the profiles of key players in Genetic Modification Therapies Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Casebia Therapeutics
- Acer Therapeutics Inc.
- 4D Molecular Therapeutics
- Beam Therapeutics
- Abeona Therapeutics
- Editas Medicine
- GE Healthcare
- Allergan Plc.
- Marcala Biotech
- Orchard Therapeutics
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Genetic Modification Therapies Market - By Platform Technology
1.3.2 Genetic Modification Therapies Market - By Delivery Technology
1.3.3 Genetic Modification Therapies Market - By End User
1.3.4 Genetic Modification Therapies Market - By Disease
1.3.5 Genetic Modification Therapies Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GENETIC MODIFICATION THERAPIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GENETIC MODIFICATION THERAPIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GENETIC MODIFICATION THERAPIES MARKET - GLOBAL MARKET ANALYSIS
6.1. GENETIC MODIFICATION THERAPIES - GLOBAL MARKET OVERVIEW
6.2. GENETIC MODIFICATION THERAPIES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GENETIC MODIFICATION THERAPIES MARKET - REVENUE AND FORECASTS TO 2028 - PLATFORM TECHNOLOGY
7.1. OVERVIEW
7.2. PLATFORM TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. GENE EDITING
7.3.1. Overview
7.3.2. Gene editing Market Forecast and Analysis
7.4. GENE THERAPIES
7.4.1. Overview
7.4.2. Gene Therapies Market Forecast and Analysis
7.5. GENETICALLY MODIFIED CELL THERAPIES
7.5.1. Overview
7.5.2. Genetically Modified Cell Therapies Market Forecast and Analysis
7.6. RNA THERAPIES
7.6.1. Overview
7.6.2. RNA Therapies Market Forecast and Analysis
8. GENETIC MODIFICATION THERAPIES MARKET - REVENUE AND FORECASTS TO 2028 - DELIVERY TECHNOLOGY
8.1. OVERVIEW
8.2. DELIVERY TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. AAV
8.3.1. Overview
8.3.2. AAV Market Forecast and Analysis
8.4. ADENOVIRUS
8.4.1. Overview
8.4.2. Adenovirus Market Forecast and Analysis
8.5. LENTIVIRUS
8.5.1. Overview
8.5.2. Lentivirus Market Forecast and Analysis
8.6. RETROVIRUS
8.6.1. Overview
8.6.2. Retrovirus Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. GENETIC MODIFICATION THERAPIES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTICS AND TESTING LABORATORIES
9.4.1. Overview
9.4.2. Diagnostics and Testing Laboratories Market Forecast and Analysis
9.5. ACADEMIC AND RESEARCH ORGANIZATIONS
9.5.1. Overview
9.5.2. Academic and Research Organizations Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. GENETIC MODIFICATION THERAPIES MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE
10.1. OVERVIEW
10.2. DISEASE MARKET FORECASTS AND ANALYSIS
10.3. CARDIOLOGY
10.3.1. Overview
10.3.2. Cardiology Market Forecast and Analysis
10.4. ONCOLOGY
10.4.1. Overview
10.4.2. Oncology Market Forecast and Analysis
10.5. OPHTHALMOLOGY
10.5.1. Overview
10.5.2. Ophthalmology Market Forecast and Analysis
10.6. HEMATOLOGY
10.6.1. Overview
10.6.2. Hematology Market Forecast and Analysis
10.7. MUSCULOSKELETAL
10.7.1. Overview
10.7.2. Musculoskeletal Market Forecast and Analysis
10.8. NEUROLOGY
10.8.1. Overview
10.8.2. Neurology Market Forecast and Analysis
10.9. OTHERS
10.9.1. Overview
10.9.2. Others Market Forecast and Analysis
11. GENETIC MODIFICATION THERAPIES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Genetic Modification Therapies Market Overview
11.1.2 North America Genetic Modification Therapies Market Forecasts and Analysis
11.1.3 North America Genetic Modification Therapies Market Forecasts and Analysis - By Platform Technology
11.1.4 North America Genetic Modification Therapies Market Forecasts and Analysis - By Delivery Technology
11.1.5 North America Genetic Modification Therapies Market Forecasts and Analysis - By End User
11.1.6 North America Genetic Modification Therapies Market Forecasts and Analysis - By Disease
11.1.7 North America Genetic Modification Therapies Market Forecasts and Analysis - By Countries
11.1.7.1 United States Genetic Modification Therapies Market
11.1.7.1.1 United States Genetic Modification Therapies Market by Platform Technology
11.1.7.1.2 United States Genetic Modification Therapies Market by Delivery Technology
11.1.7.1.3 United States Genetic Modification Therapies Market by End User
11.1.7.1.4 United States Genetic Modification Therapies Market by Disease
11.1.7.2 Canada Genetic Modification Therapies Market
11.1.7.2.1 Canada Genetic Modification Therapies Market by Platform Technology
11.1.7.2.2 Canada Genetic Modification Therapies Market by Delivery Technology
11.1.7.2.3 Canada Genetic Modification Therapies Market by End User
11.1.7.2.4 Canada Genetic Modification Therapies Market by Disease
11.1.7.3 Mexico Genetic Modification Therapies Market
11.1.7.3.1 Mexico Genetic Modification Therapies Market by Platform Technology
11.1.7.3.2 Mexico Genetic Modification Therapies Market by Delivery Technology
11.1.7.3.3 Mexico Genetic Modification Therapies Market by End User
11.1.7.3.4 Mexico Genetic Modification Therapies Market by Disease
11.2. EUROPE
11.2.1 Europe Genetic Modification Therapies Market Overview
11.2.2 Europe Genetic Modification Therapies Market Forecasts and Analysis
11.2.3 Europe Genetic Modification Therapies Market Forecasts and Analysis - By Platform Technology
11.2.4 Europe Genetic Modification Therapies Market Forecasts and Analysis - By Delivery Technology
11.2.5 Europe Genetic Modification Therapies Market Forecasts and Analysis - By End User
11.2.6 Europe Genetic Modification Therapies Market Forecasts and Analysis - By Disease
11.2.7 Europe Genetic Modification Therapies Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Genetic Modification Therapies Market
11.2.7.1.1 Germany Genetic Modification Therapies Market by Platform Technology
11.2.7.1.2 Germany Genetic Modification Therapies Market by Delivery Technology
11.2.7.1.3 Germany Genetic Modification Therapies Market by End User
11.2.7.1.4 Germany Genetic Modification Therapies Market by Disease
11.2.7.2 France Genetic Modification Therapies Market
11.2.7.2.1 France Genetic Modification Therapies Market by Platform Technology
11.2.7.2.2 France Genetic Modification Therapies Market by Delivery Technology
11.2.7.2.3 France Genetic Modification Therapies Market by End User
11.2.7.2.4 France Genetic Modification Therapies Market by Disease
11.2.7.3 Italy Genetic Modification Therapies Market
11.2.7.3.1 Italy Genetic Modification Therapies Market by Platform Technology
11.2.7.3.2 Italy Genetic Modification Therapies Market by Delivery Technology
11.2.7.3.3 Italy Genetic Modification Therapies Market by End User
11.2.7.3.4 Italy Genetic Modification Therapies Market by Disease
11.2.7.4 Spain Genetic Modification Therapies Market
11.2.7.4.1 Spain Genetic Modification Therapies Market by Platform Technology
11.2.7.4.2 Spain Genetic Modification Therapies Market by Delivery Technology
11.2.7.4.3 Spain Genetic Modification Therapies Market by End User
11.2.7.4.4 Spain Genetic Modification Therapies Market by Disease
11.2.7.5 United Kingdom Genetic Modification Therapies Market
11.2.7.5.1 United Kingdom Genetic Modification Therapies Market by Platform Technology
11.2.7.5.2 United Kingdom Genetic Modification Therapies Market by Delivery Technology
11.2.7.5.3 United Kingdom Genetic Modification Therapies Market by End User
11.2.7.5.4 United Kingdom Genetic Modification Therapies Market by Disease
11.2.7.6 Rest of Europe Genetic Modification Therapies Market
11.2.7.6.1 Rest of Europe Genetic Modification Therapies Market by Platform Technology
11.2.7.6.2 Rest of Europe Genetic Modification Therapies Market by Delivery Technology
11.2.7.6.3 Rest of Europe Genetic Modification Therapies Market by End User
11.2.7.6.4 Rest of Europe Genetic Modification Therapies Market by Disease
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Genetic Modification Therapies Market Overview
11.3.2 Asia-Pacific Genetic Modification Therapies Market Forecasts and Analysis
11.3.3 Asia-Pacific Genetic Modification Therapies Market Forecasts and Analysis - By Platform Technology
11.3.4 Asia-Pacific Genetic Modification Therapies Market Forecasts and Analysis - By Delivery Technology
11.3.5 Asia-Pacific Genetic Modification Therapies Market Forecasts and Analysis - By End User
11.3.6 Asia-Pacific Genetic Modification Therapies Market Forecasts and Analysis - By Disease
11.3.7 Asia-Pacific Genetic Modification Therapies Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Genetic Modification Therapies Market
11.3.7.1.1 Australia Genetic Modification Therapies Market by Platform Technology
11.3.7.1.2 Australia Genetic Modification Therapies Market by Delivery Technology
11.3.7.1.3 Australia Genetic Modification Therapies Market by End User
11.3.7.1.4 Australia Genetic Modification Therapies Market by Disease
11.3.7.2 China Genetic Modification Therapies Market
11.3.7.2.1 China Genetic Modification Therapies Market by Platform Technology
11.3.7.2.2 China Genetic Modification Therapies Market by Delivery Technology
11.3.7.2.3 China Genetic Modification Therapies Market by End User
11.3.7.2.4 China Genetic Modification Therapies Market by Disease
11.3.7.3 India Genetic Modification Therapies Market
11.3.7.3.1 India Genetic Modification Therapies Market by Platform Technology
11.3.7.3.2 India Genetic Modification Therapies Market by Delivery Technology
11.3.7.3.3 India Genetic Modification Therapies Market by End User
11.3.7.3.4 India Genetic Modification Therapies Market by Disease
11.3.7.4 Japan Genetic Modification Therapies Market
11.3.7.4.1 Japan Genetic Modification Therapies Market by Platform Technology
11.3.7.4.2 Japan Genetic Modification Therapies Market by Delivery Technology
11.3.7.4.3 Japan Genetic Modification Therapies Market by End User
11.3.7.4.4 Japan Genetic Modification Therapies Market by Disease
11.3.7.5 South Korea Genetic Modification Therapies Market
11.3.7.5.1 South Korea Genetic Modification Therapies Market by Platform Technology
11.3.7.5.2 South Korea Genetic Modification Therapies Market by Delivery Technology
11.3.7.5.3 South Korea Genetic Modification Therapies Market by End User
11.3.7.5.4 South Korea Genetic Modification Therapies Market by Disease
11.3.7.6 Rest of Asia-Pacific Genetic Modification Therapies Market
11.3.7.6.1 Rest of Asia-Pacific Genetic Modification Therapies Market by Platform Technology
11.3.7.6.2 Rest of Asia-Pacific Genetic Modification Therapies Market by Delivery Technology
11.3.7.6.3 Rest of Asia-Pacific Genetic Modification Therapies Market by End User
11.3.7.6.4 Rest of Asia-Pacific Genetic Modification Therapies Market by Disease
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Genetic Modification Therapies Market Overview
11.4.2 Middle East and Africa Genetic Modification Therapies Market Forecasts and Analysis
11.4.3 Middle East and Africa Genetic Modification Therapies Market Forecasts and Analysis - By Platform Technology
11.4.4 Middle East and Africa Genetic Modification Therapies Market Forecasts and Analysis - By Delivery Technology
11.4.5 Middle East and Africa Genetic Modification Therapies Market Forecasts and Analysis - By End User
11.4.6 Middle East and Africa Genetic Modification Therapies Market Forecasts and Analysis - By Disease
11.4.7 Middle East and Africa Genetic Modification Therapies Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Genetic Modification Therapies Market
11.4.7.1.1 South Africa Genetic Modification Therapies Market by Platform Technology
11.4.7.1.2 South Africa Genetic Modification Therapies Market by Delivery Technology
11.4.7.1.3 South Africa Genetic Modification Therapies Market by End User
11.4.7.1.4 South Africa Genetic Modification Therapies Market by Disease
11.4.7.2 Saudi Arabia Genetic Modification Therapies Market
11.4.7.2.1 Saudi Arabia Genetic Modification Therapies Market by Platform Technology
11.4.7.2.2 Saudi Arabia Genetic Modification Therapies Market by Delivery Technology
11.4.7.2.3 Saudi Arabia Genetic Modification Therapies Market by End User
11.4.7.2.4 Saudi Arabia Genetic Modification Therapies Market by Disease
11.4.7.3 U.A.E Genetic Modification Therapies Market
11.4.7.3.1 U.A.E Genetic Modification Therapies Market by Platform Technology
11.4.7.3.2 U.A.E Genetic Modification Therapies Market by Delivery Technology
11.4.7.3.3 U.A.E Genetic Modification Therapies Market by End User
11.4.7.3.4 U.A.E Genetic Modification Therapies Market by Disease
11.4.7.4 Rest of Middle East and Africa Genetic Modification Therapies Market
11.4.7.4.1 Rest of Middle East and Africa Genetic Modification Therapies Market by Platform Technology
11.4.7.4.2 Rest of Middle East and Africa Genetic Modification Therapies Market by Delivery Technology
11.4.7.4.3 Rest of Middle East and Africa Genetic Modification Therapies Market by End User
11.4.7.4.4 Rest of Middle East and Africa Genetic Modification Therapies Market by Disease
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Genetic Modification Therapies Market Overview
11.5.2 South and Central America Genetic Modification Therapies Market Forecasts and Analysis
11.5.3 South and Central America Genetic Modification Therapies Market Forecasts and Analysis - By Platform Technology
11.5.4 South and Central America Genetic Modification Therapies Market Forecasts and Analysis - By Delivery Technology
11.5.5 South and Central America Genetic Modification Therapies Market Forecasts and Analysis - By End User
11.5.6 South and Central America Genetic Modification Therapies Market Forecasts and Analysis - By Disease
11.5.7 South and Central America Genetic Modification Therapies Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Genetic Modification Therapies Market
11.5.7.1.1 Brazil Genetic Modification Therapies Market by Platform Technology
11.5.7.1.2 Brazil Genetic Modification Therapies Market by Delivery Technology
11.5.7.1.3 Brazil Genetic Modification Therapies Market by End User
11.5.7.1.4 Brazil Genetic Modification Therapies Market by Disease
11.5.7.2 Argentina Genetic Modification Therapies Market
11.5.7.2.1 Argentina Genetic Modification Therapies Market by Platform Technology
11.5.7.2.2 Argentina Genetic Modification Therapies Market by Delivery Technology
11.5.7.2.3 Argentina Genetic Modification Therapies Market by End User
11.5.7.2.4 Argentina Genetic Modification Therapies Market by Disease
11.5.7.3 Rest of South and Central America Genetic Modification Therapies Market
11.5.7.3.1 Rest of South and Central America Genetic Modification Therapies Market by Platform Technology
11.5.7.3.2 Rest of South and Central America Genetic Modification Therapies Market by Delivery Technology
11.5.7.3.3 Rest of South and Central America Genetic Modification Therapies Market by End User
11.5.7.3.4 Rest of South and Central America Genetic Modification Therapies Market by Disease
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. GENETIC MODIFICATION THERAPIES MARKET, KEY COMPANY PROFILES
13.1. CASEBIA THERAPEUTICS
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ACER THERAPEUTICS INC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. 4D MOLECULAR THERAPEUTICS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BEAM THERAPEUTICS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ABEONA THERAPEUTICS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. EDITAS MEDICINE
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. GE HEALTHCARE
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ALLERGAN PLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. MARCALA BIOTECH
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ORCHARD THERAPEUTICS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Casebia Therapeutics
2. Acer Therapeutics Inc
3. 4D Molecular Therapeutics
4. Beam Therapeutics
5. Abeona Therapeutics
6. Editas Medicine
7. GE Healthcare
8. Allergan Plc
9. Marcala Biotech
10. Orchard Therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Genetic Modification Therapies Market
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Apr 2024